FDA Approves Generic Versions of Lilly's Antidepressant Cymbalta

The FDA has granted approval for the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription antidepressant that is currently Eli Lilly's top-selling drug.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news